Newly Released Video Shows Bill Gates Openly Mocking Donald Trump, and the President Won't Like It One Bit
The acronym HIV stands for Human Immunodeficiency Virus, while HPV stands for Human PapillomaVirus. We may not all know the exact words associated with each acronym, but most know the difference between the medical conditions associated with the two.
Grindr has found itself in a bit of a sticky situation. The dating app, which is used predominantly by gay, bisexual, and transgender men, currently has over 3.6 million daily users. It recently came under fire when it was discovered that the app had allowed third parties to access encrypted data. As a result, Grindr announced that it will stop sharing this data, which includes the HIV status of its users, effective immediately.
Among other kinds of sensitive data, Grindr admitted that it had shared its users HIV status and date of last testing with two companies, Apptimize and Localytics. Those companies were paid to monitor and analyze the data that Grindr provided.
As part of his 2019 budget, President Trump is cutting funding for HIV/AIDS programs — again. This is a significant blow to people living with HIV/AIDS and not the first time that Trump has demonstrated a lack of support for those programs.
According to The Huffington Post, the proposed cuts include slashing $40 million in funding from the Centers for Disease Control HIV/AIDS prevention programs, as well as cutting $24 million in federal housing programs for persons living with HIV/AIDS. Similar to other legislation proposed by the Trump administration, these cuts send a clear message of Trump’s utter disregard for LGBTQ Americans. Some analysts believe that Trump’s actions could contribute to nearly 300,000 deaths globally.
A new study published in Science reports the development of an antibody that can treat and even prevent HIV infection. The International AIDS Society considers this advancement an “exciting breakthrough” in the fight against the virus, which claims an average of 1 million people a year.
A collaboration between pharmaceutical company Sanofi and the National Institutes of Health (NIH), including scientists from Harvard Medical School, The Scripps Research Institute, and the Massachusetts Institute of Technology, the study found a way to target 99 percent of known HIV strains by enhancing already existing antibodies found in some but not all HIV-positive people.
On the opening day of the 2017 International AIDS Conference in Paris, researchers presented a stunning case: a 9-year-old South African child who had been born with HIV was now free of the infection. The child, who remains unnamed to protect confidentiality, was part of a trial of 143 babies with HIV all given 40 weeks of antiretroviral medication beginning at 32 days old. By 40 weeks, the baby’s immune system did not show any symptoms of HIV and was the only child to exhibit such results.
Researchers were cautiously optimistic as this result harked back to the brief success of the “Mississippi Baby,” who had been treated for HIV infection after her birth in 2010 until 18 months old. A year after stopping the medication, they still could not detect the HIV virus in her blood. But their celebrations were short-lived. By 2014, the virus had rebounded, as it often does. The South African child, in contrast, remains HIV free almost a decade later.